Novo Holdings A/S's Form 4 filing
IO Biotech, Inc. (IOBT) · filed Aug 11, 2023
- Accession no.
- 0001209191-23-045444
- Filed
- Aug 11, 2023
- Trade date
- Aug 9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $5.01M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novo Holdings A/SCIK 0001388325 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +2,469,135 | $2.03F1 | +$5,012,344.05 | 5,707,467 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | PPurchaseAcquired | +2,469,135 | $2.03F1 | +$5,012,344.05 | 2,469,135 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a combined purchase price of $2.025 for Common Stock and Warrants from Issuer in a private placement.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.